grant

4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center

Organization UNIVERSITY OF ALABAMA AT BIRMINGHAMLocation BIRMINGHAM, UNITED STATESPosted 25 Sept 2017Deadline 31 May 2028
NIHUS FederalResearch GrantFY20250-11 years oldAccelerationActive Follow-upAcuteAddressAfrican AmericanAfrican American groupAfrican American individualAfrican American peopleAfrican American populationAfrican AmericansAfrican ancestryAfrican descentAfro AmericanAfroamericanAlabamaAlbuminsAllograftingAmericanAntibodiesApolipoproteinsArkansasBacterial InfectionsBiopsyBloodBlood Reticuloendothelial SystemBlood SerumChildChild YouthChildren (0-21)ClinicalClinical DataConsentCost SavingsCounselingCreatinineDNADataDeoxyribonucleic AcidDisparitiesDisparityDonor personEducationEducational aspectsEnrollmentEnsureEnvironmental FactorEnvironmental Risk FactorEuropeanEvaluationFaceFailureFoundationsGene variantGenesGeneticGenetic predisposing factorGenotypeGeographyGraft SurvivalHL-A AntigensHLA AntigensHealth Care CostsHealth CostsHuman Leukocyte AntigensImmunosuppressionImmunosuppression EffectImmunosuppressive EffectIndividualInformed ConsentKidneyKidney DiseasesKidney FailureKidney GraftingKidney InsufficiencyKidney TransplantationKidney TransplantsKidney Urinary SystemLeadLesionLeukocyte AntigensLiving DonorsLong-term Follow-upMeasuresMedicalMedical centerMississippiNational Institutes of HealthNephropathyOrganOutcomeOutcome AssessmentOutcome StudyParticipantPatternPb elementPersonsPhasePhenotypePoliciesPrevalenceProcessProteinuriaQOLQuality of lifeRecurrent diseaseRegistriesRelapsed DiseaseRenal DiseaseRenal FailureRenal GraftingRenal InsufficiencyRenal TransplantationRenal TransplantsRenal functionReportingResearchRiskRisk-associated variantRoleSafetyScienceSerumSiteSlideSouth CarolinaTimeTransplant RecipientsTransplantationUNOSUnited Network for Organ SharingUnited States National Institutes of HealthUniversitiesUrineVariantVariationViral DiseasesVirus Diseasesactive followupallelic variantbacteria infectionbacterial diseaseclinical centerco-morbidco-morbiditycohortcomorbiditydamage to kidneydeceased donordeceased organ donorsdepositorydifferences due to racedifferences in racediffers by racediffers in racedigital pathologyenrollenvironmental riskethnic differenceethnicity differencefacesfacialfollow upfollow-upfollowed upfollowupgene interactiongenetic risk factorgenetic variantgenomic variantgraft failureheavy metal Pbheavy metal leadhigh riskimmune suppressionimmune suppressive activityimmune suppressive functionimmunosuppressive activityimmunosuppressive functionimmunosuppressive responseimprovedinherited factorkidney allograftkidney biopsykidney damagekidney disorderkidney functionkidney txkidslive kidney donorliving kidney donorlong-term followupnovelorgan allocationphase 2 studyphase II studypost-transplantpost-transplantationposthumous donorsposthumous organ donorposttransplantposttransplantationprimary outcomeprogramsprospectiverace based differencesrace differencesrace related differencesracial differenceracially differentrecruitrenalrenal allograftrenal biopsyrenal damagerenal disorderrepositoryrisk allelerisk generisk genotyperisk locirisk locusrisk variantsecondary outcomesocial roletransplanttransplant donortransplant patientviral infectionvirus infectionvirus-induced diseaseyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Abstract
Kidneys from deceased African American donors have reduced allograft survival compared to kidneys from

donors from European Americans. Likewise, kidneys from deceased donors with 2 apolipoprotein L1 gene

(APOL1) renal-risk variants, defined as APOL1 high-risk genotypes, have shorter allograft survival. Importantly,

many kidneys…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center — UNIVERSITY OF ALABAMA AT BIRMING | Dev Procure